Abstract
Stroke is a disease that causes a substantial economic burden. With the rapidly aging population in Korea, the prevalence of chronic diseases, including stroke, is expected to rise, along with associated health care expenditures. Therefore, we estimated the economic burden of stroke in Korea in 2010 using nationally representative data. We used a prevalence-based approach to estimate the cost of stroke by claims data from the Korean National Health Insurance. Data from the Korea Health Panel, the Korea National Statistical Office's records of causes of death, and Labor Statistics were used to calculate direct non-medical costs and indirect costs. Direct costs included direct medical costs and direct non-medical costs, and indirect costs were opportunity costs lost due to premature death and productivity loss. Total costs were estimated by adding age- and gender-specific costs. The total economic burden of stroke was $3.53 billion: $1.87 billion for hemorrhagic stroke and $1.66 billion for ischemic stroke. The direct costs were $1.74 billion and the indirect costs were $1.79 billion. By gender, males were burdened at $2.19 billion, while females bore $1.34 billion of the total burden. Stroke imposes a huge economic burden, as indicated by the fact that the costs of stroke increased by 4.4% from 2005 to 2010, and the estimated cost was 0.35% of gross domestic product. Therefore, effective prevention programs and treatments are needed to reduce the economic burden of stroke in Korea.
| Original language | English |
|---|---|
| Pages (from-to) | 1226-1236 |
| Number of pages | 11 |
| Journal | Journal of the Korean Medical Association |
| Volume | 55 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2012 Dec 1 |
Fingerprint
Keywords
- Cost of illness
- Economic burden
- Prevention & control
- Stroke
ASJC Scopus subject areas
- Medicine(all)
Cite this
The economic burden of stroke in 2010 in Korea. / Kim, Hyun Jin; Kim, Young Ae; Seo, Hye Young; Kim, Eun Jung; Yoon, Seok-Jun; Oh, In Hwan.
In: Journal of the Korean Medical Association, Vol. 55, No. 12, 01.12.2012, p. 1226-1236.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The economic burden of stroke in 2010 in Korea
AU - Kim, Hyun Jin
AU - Kim, Young Ae
AU - Seo, Hye Young
AU - Kim, Eun Jung
AU - Yoon, Seok-Jun
AU - Oh, In Hwan
PY - 2012/12/1
Y1 - 2012/12/1
N2 - Stroke is a disease that causes a substantial economic burden. With the rapidly aging population in Korea, the prevalence of chronic diseases, including stroke, is expected to rise, along with associated health care expenditures. Therefore, we estimated the economic burden of stroke in Korea in 2010 using nationally representative data. We used a prevalence-based approach to estimate the cost of stroke by claims data from the Korean National Health Insurance. Data from the Korea Health Panel, the Korea National Statistical Office's records of causes of death, and Labor Statistics were used to calculate direct non-medical costs and indirect costs. Direct costs included direct medical costs and direct non-medical costs, and indirect costs were opportunity costs lost due to premature death and productivity loss. Total costs were estimated by adding age- and gender-specific costs. The total economic burden of stroke was $3.53 billion: $1.87 billion for hemorrhagic stroke and $1.66 billion for ischemic stroke. The direct costs were $1.74 billion and the indirect costs were $1.79 billion. By gender, males were burdened at $2.19 billion, while females bore $1.34 billion of the total burden. Stroke imposes a huge economic burden, as indicated by the fact that the costs of stroke increased by 4.4% from 2005 to 2010, and the estimated cost was 0.35% of gross domestic product. Therefore, effective prevention programs and treatments are needed to reduce the economic burden of stroke in Korea.
AB - Stroke is a disease that causes a substantial economic burden. With the rapidly aging population in Korea, the prevalence of chronic diseases, including stroke, is expected to rise, along with associated health care expenditures. Therefore, we estimated the economic burden of stroke in Korea in 2010 using nationally representative data. We used a prevalence-based approach to estimate the cost of stroke by claims data from the Korean National Health Insurance. Data from the Korea Health Panel, the Korea National Statistical Office's records of causes of death, and Labor Statistics were used to calculate direct non-medical costs and indirect costs. Direct costs included direct medical costs and direct non-medical costs, and indirect costs were opportunity costs lost due to premature death and productivity loss. Total costs were estimated by adding age- and gender-specific costs. The total economic burden of stroke was $3.53 billion: $1.87 billion for hemorrhagic stroke and $1.66 billion for ischemic stroke. The direct costs were $1.74 billion and the indirect costs were $1.79 billion. By gender, males were burdened at $2.19 billion, while females bore $1.34 billion of the total burden. Stroke imposes a huge economic burden, as indicated by the fact that the costs of stroke increased by 4.4% from 2005 to 2010, and the estimated cost was 0.35% of gross domestic product. Therefore, effective prevention programs and treatments are needed to reduce the economic burden of stroke in Korea.
KW - Cost of illness
KW - Economic burden
KW - Prevention & control
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=84872132632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872132632&partnerID=8YFLogxK
U2 - 10.5124/jkma.2012.55.12.1226
DO - 10.5124/jkma.2012.55.12.1226
M3 - Article
AN - SCOPUS:84872132632
VL - 55
SP - 1226
EP - 1236
JO - Journal of the Korean Medical Association
JF - Journal of the Korean Medical Association
SN - 1975-8456
IS - 12
ER -